Hi List, Does anyone have an idea of B cell antibodies to use to follow disease in B cell lymphomas with patients now being given anti-CD22(Epratuzumab) and anti-CD20(Rituxamab) besides CD19? Thanks, Paula Paula Imus Flow Cytometry LP, NCI, NIH 10 Center Drive MSC-1500 Bethesda, Md. 20892-1500
This archive was generated by hypermail 2b29 : Sun Jan 05 2003 - 19:26:10 EST